Birsfelden, Switzerland

Jürg Paul Ris


 

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jürg Paul Ris in Fluid Bed Technology

Introduction

Jürg Paul Ris is a notable inventor based in Birsfelden, Switzerland. He has made significant contributions to the field of coating technologies, particularly through his innovative designs in fluid bed apparatuses. His work focuses on enhancing the efficiency and effectiveness of coating solid particles.

Latest Patents

Jürg Paul Ris holds a patent for a "Fluid bed apparatus for coating solid particles." This apparatus features a housing with upwardly extending walls that surround a perforated base plate. It includes a nozzle for atomizing a coating liquid, strategically placed within the walls, and a device for providing fluidization gas through the base plate's perforations. This design allows for the maintenance of a fluidized layer, which is crucial for the coating process. The nozzle is located in a channel that facilitates the co-current introduction of a dispersion gas, with an orifice radius of 5 mm or more. This innovative apparatus is designed to produce particles with smooth surfaces, high yield, and a reduced tendency to form agglomerates.

Career Highlights

Jürg Paul Ris is associated with Gea Pharma Systems AG, a company known for its advanced pharmaceutical processing technologies. His work at Gea Pharma Systems AG has allowed him to apply his innovative ideas in a practical setting, contributing to the development of efficient coating solutions in the pharmaceutical industry.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Jürg Paul Ris's contributions to fluid bed technology exemplify the importance of innovation in the pharmaceutical industry. His patent for a fluid bed apparatus showcases his commitment to improving coating processes, ultimately benefiting the production of high-quality pharmaceutical products.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…